These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34698318)

  • 1. [COVID-19 immunizations in occupational medicine].
    Kuchar EP; Karlikowska-Skwarnik M
    Med Pr; 2021 Dec; 72(6):701-710. PubMed ID: 34698318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of interest in vaccination against COVID-19 and other pro-health initiatives at the workplace among employees in Poland.
    Olearczyk A; Olejniczak D
    Med Pr; 2021 Dec; 72(6):653-659. PubMed ID: 34889316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
    Teran RA; Walblay KA; Shane EL; Xydis S; Gretsch S; Gagner A; Samala U; Choi H; Zelinski C; Black SR
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):632-638. PubMed ID: 33914721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quarantine and Mental Health Challenges for Occupational Medicine: The Case Report of a Nurse Infected With SARS-CoV-2.
    Buselli R; Corsi M; Veltri A; Baldanzi S; Chiumiento M; Del Lupo E; Marino R; Necciari G; Caldi F; Perretta S; Foddis R; Guglielmi G; Cristaudo A
    Workplace Health Saf; 2022 Jan; 70(1):43-49. PubMed ID: 35037513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns.
    Zellweger RM; Wartel TA; Marks F; Song M; Kim JH
    Expert Rev Vaccines; 2020 Aug; 19(8):691-698. PubMed ID: 32838605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Do we need a pediatric COVID-19 vaccine?].
    Eberhardt CS; Siegrist CA
    Rev Med Suisse; 2021 Feb; 17(726):353-357. PubMed ID: 33599412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
    Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
    EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
    Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
    Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19.
    Rao CY; Robinson T; Huster K; Laws RL; Keating R; Tobolowsky FA; McMichael TM; Gonzales E; Mosites E
    PLoS One; 2021; 16(11):e0253108. PubMed ID: 34723986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.
    Brehm TT; Thompson M; Ullrich F; Schwinge D; Addo MM; Spier A; Knobloch JK; Aepfelbacher M; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    Int J Hyg Environ Health; 2021 Sep; 238():113851. PubMed ID: 34601375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients with HIV infection].
    AIDS and Hepatitis C Professional Group, Chinese Society of Infectious Diseases
    Zhonghua Nei Ke Za Zhi; 2021 Jul; 60(7):615-618. PubMed ID: 34619837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.
    Rastawicki W; Płaza K
    Przegl Epidemiol; 2021; 75(1):3-13. PubMed ID: 34328282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App.
    Braun P; Haffner S; Woodcock BG
    Int J Clin Pharmacol Ther; 2020 Aug; 58(8):417-425. PubMed ID: 32646540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.